- Home
- GLAD vs CYRX Comparison
GLAD vs CYRX Comparison
Compare GLAD & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLAD
- CYRX
- Stock Information
- Founded
- GLAD 2001
- CYRX 1999
- Country
- GLAD United States
- CYRX United States
- Employees
- GLAD N/A
- CYRX N/A
- Industry
- GLAD Finance/Investors Services
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- GLAD Finance
- CYRX Health Care
- Exchange
- GLAD Nasdaq
- CYRX Nasdaq
- Market Cap
- GLAD 482.1M
- CYRX 438.7M
- IPO Year
- GLAD N/A
- CYRX N/A
- Fundamental
- Price
- GLAD $19.35
- CYRX $9.04
- Analyst Decision
- GLAD Hold
- CYRX Strong Buy
- Analyst Count
- GLAD 2
- CYRX 9
- Target Price
- GLAD $25.75
- CYRX $12.56
- AVG Volume (30 Days)
- GLAD 298.0K
- CYRX 740.2K
- Earning Date
- GLAD 11-17-2025
- CYRX 11-04-2025
- Dividend Yield
- GLAD 10.77%
- CYRX N/A
- EPS Growth
- GLAD N/A
- CYRX N/A
- EPS
- GLAD 3.38
- CYRX 1.35
- Revenue
- GLAD $88,900,000.00
- CYRX $237,879,000.00
- Revenue This Year
- GLAD N/A
- CYRX N/A
- Revenue Next Year
- GLAD $16.05
- CYRX $9.20
- P/E Ratio
- GLAD $5.72
- CYRX $6.69
- Revenue Growth
- GLAD N/A
- CYRX 24.93
- 52 Week Low
- GLAD $18.90
- CYRX $4.58
- 52 Week High
- GLAD $30.43
- CYRX $11.44
- Technical
- Relative Strength Index (RSI)
- GLAD 34.49
- CYRX 43.37
- Support Level
- GLAD $19.00
- CYRX $8.95
- Resistance Level
- GLAD $19.91
- CYRX $11.11
- Average True Range (ATR)
- GLAD 0.47
- CYRX 0.75
- MACD
- GLAD 0.16
- CYRX -0.18
- Stochastic Oscillator
- GLAD 32.14
- CYRX 7.69
About GLAD Gladstone Capital Corporation
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.